Aug. 6 at 2:46 AM
$BFLY The second half of 2026 and first half of 2027 will bring revenue growth and expansion of multiple pipelines. The stock won’t be in the
$7-8 for too long. We could see the stock at
$11-12 by end of Q1 2027.
- Revenue growth from Brazilian market
- Final approval for FedRamp Certification will allow sales to VA and all federal government agencies.
- Butterfly Home & Community Care entering commercial application. Once the program begins to generate cost savings for Optum there will be quick expansion into other states. Home healthcare takes
$BFLY from
$120 million revenues in 2026 to
$180-200 million by end of 2027.
- FDA approval for 4th Gen chip
- Release of Apollo likely a year earlier than prior estimates. Apollo will be a game changer for BFLY and companies globally waiting for the chip.
- iQ4 workstations for enterprise solutions to large institutions.
- New partnerships for Butterfly Embedded, Compass AI, Butterfly Garden.
Few Understand 🦋
$AAPL $PLTR $ARKG
